Patents by Inventor Mona Patel

Mona Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intra-luminal device for treatment of body cavities and lumens and method of use
    Patent number: 6093199
    Abstract: An intra-luminal device comprises a flow retainer and/or modulator for maintaining an embolic mass within an aneurysm and, optionally, for diverting or modulating fluid flow, and an anchoring element for fixating the retainer within a lumen in a patient's body. The retainer is introduced into the body lumen and positioned with the retainer across the entrance to a body cavity or a body lumen with an embolic mass disposed within to prevent the embolic mass from migrating into the patient's vasculature. The retainer may also be a diverter or modulator used to divert or modulate the luminal fluid flow to the entrance to the body cavity or lumen. The anchoring element, which may be attached to the retainer, is deployed to permanently secure the retainer within the body lumen in the desired position.
    Type: Grant
    Filed: August 5, 1998
    Date of Patent: July 25, 2000
    Assignee: Endovascular Technologies, Inc.
    Inventors: Peter S. Brown, Mary Bellack, Mona Patel
  • Substituted quinolin-2 (1H)-ones useful as HIV reverse transcriptase inhibitors
    Patent number: 6090821
    Abstract: This invention relates generally to quinolin-2(1H)-ones and derivatives thereof of Formula (I): ##STR1## or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, pharmaceutical compositions and diagnostic kits comprising the same, methods of using the same for treating viral infection or as assay standards or reagents, and intermediates and processes for making the same.
    Type: Grant
    Filed: June 29, 1999
    Date of Patent: July 18, 2000
    Assignee: E. I. DuPont de Nemours and Company
    Inventors: Mona Patel, James D. Rodgers
  • 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
    Patent number: 5874430
    Abstract: The present invention relates to benzoxazinones of formula I: ##STR1## or stereoisomeric forms or mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, methods of using the same for treating viral infection or as an assay standard or reagent, and intermediates and processes for making the same.
    Type: Grant
    Filed: October 1, 1997
    Date of Patent: February 23, 1999
    Assignee: DuPont Pharmaceuticals Company
    Inventors: David Donald Christ, Anthony Joseph Cocuzza, Soo Sung Ko, Jay Andrew Markwalder, Abdul Ezaz Mutlib, Rodney Lawrence Parsons, Jr., Mona Patel, Steven Paul Seitz